Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension

NCT00737594 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Failure to enroll a suitable number of qualified subjects.

Conditions

Portal Hypertension

Interventions

DRUG: Placebo
DRUG: Cobiprostone

Sponsor

Sucampo Pharma Americas, LLC

Collaborators

[object Object]